Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

PMA for KeraVision Ring accepted for filing

Sep. 3, 1998

IL-1 blockers CK-119 and CK-122 inhibit corneal fibroblast-like cell proliferation

Aug. 28, 1998

Future antiglaucoma drug candidates added to the pipeline at Alcon

Aug. 24, 1998

PGF2alpha derivative from Allergan reduces ocular hypertension in monkeys

Aug. 20, 1998

Sugen reaches milestone in collaborative agreement with Allergan

Aug. 10, 1998

First SELEX compound from NeXstar heads for clinical trials in ARMD

July 27, 1998

Troponin I inhibits retinal angiogenesis in animal studies

July 27, 1998

Herpes simplex virus vaccine reduces HSV-1 corneal disease

July 24, 1998

BioLon receives FDA approval

July 23, 1998

FDA grants fast track status to Miravant's Purlytin

July 10, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...